Organto Files Preliminary Base Shelf Prospectus

Rhea-AI Summary

Organto Foods Inc. (TSXV:OGO)(OTCQB:OGOFF)(FSE:OGF) announces the filing of a preliminary short form base shelf prospectus, enabling the company to make offerings of up to CDN $50 million. The net proceeds may be used for general corporate purposes, reducing indebtedness, and potential future acquisitions. Additionally, the company has engaged Atrium Research to provide paid equity research and investor relations services for an initial 12-month period.

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES

TORONTO, ON, and BREDA, THE NETHERLANDS / ACCESSWIRE / August 3, 2023 / Organto Foods Inc. (TSXV:OGO)(OTCQB:OGOFF)(FSE:OGF) ("Organto" or "the Company"), a leading provider of organic and value-added organic fruits and vegetables, today announced that it has filed a preliminary short form base shelf prospectus with the securities regulators in each province and territory of Canada.

This filing renews Organto's final short form base shelf prospectus, dated July 5, 2021, and, when made final or effective, will allow the Company to make offerings of common shares, debt securities, convertible securities, warrants and subscription receipts or any combination thereof of up to CDN $50 million during the 25-month period that the shelf prospectus is effective. The net proceeds from any such offerings may be used by the Company for general corporate purposes, including funding ongoing operations and/or capital requirements, reducing the level of indebtedness outstanding from time to time, settling obligations outstanding from time to time, discretionary capital programs and potential future acquisitions.

The Company has filed this new preliminary base shelf prospectus with a view to maintaining financial flexibility, but has no immediate intention to undertake an offering. The specific terms of any future offering will be established in a prospectus supplement to the base shelf prospectus and this supplement will be filed with the applicable Canadian securities regulatory authorities at the time any such offering is made.

This news release does not constitute an offer of any securities for sale.

A copy of the preliminary short form base shelf prospectus can be found on SEDAR+ at www.sedarplus.com.

Engagement of Atrium Research

Organto also announced today that it has engaged Atrium Research (the "Consultant") to provide institutional quality paid equity research and investor relations services pursuant to an Agreement dated April 1, 2023. Services will include the production and publication of research reports and periodic updates and distribution of these reports and updates to the Consultant's e-mail list and website. In consideration of these services, the Company has agreed to pay the Consultant a fee of CDN $3,000 per month for an initial 12-month period. The Consultant is an arms-length party to the Company and will not purchase securities in the Company from time to time for investment purposes.

ON BEHALF OF ORGANTO,

Steve Bromley
Chair and Co-CEO

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

For more information contact:

Investor Relations
info@organto.com

ABOUT ORGANTO

Organto is an integrated provider of branded, private label and distributed organic and non-GMO fruit and vegetable products using a strategic asset-light business model to serve a growing socially responsible and health-conscious consumer around the globe. Organto's business model is rooted in its commitment to sustainable business practices focused on environmental responsibility and a commitment to the communities where it operates, its people and its shareholders.

CAUTION CONCERNING FORWARD LOOKING STATEMENTS

Certain statements included in this release may be "forward-looking statements" within the meaning of Canadian securities laws. Forward-looking statements are typically identified by the use of terminology such as "may", "will", "would", "could", "expects", "plans", "intends", "anticipates" or "believes" or the negative or other variations of these words or other comparable words or phrases. Forward-looking statements, by their nature, are based on assumptions, and are subject to important risks and uncertainties. Forward-looking statements cannot be relied upon due to, amongst other things, changing external events and general uncertainties of the business. Actual results may differ materially from results indicated in forward-looking statements due to a number of factors, including those identified in Organto's annual information form and management's discussion and analysis of financial condition and results of operations. The forward-looking statements contained in this release represent Organto's expectations as of the date of this release (or as of the date they are otherwise stated to be made), and are subject to change after such date. However, Organto disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required under applicable securities regulations.

SOURCE: Organto Foods Inc.

View source version on accesswire.com:
https://www.accesswire.com/771971/Organto-Files-Preliminary-Base-Shelf-Prospectus

FAQ

What did Organto Foods Inc. announce?

Organto Foods Inc. announced the filing of a preliminary short form base shelf prospectus, enabling the company to make offerings of up to CDN $50 million.

How will the net proceeds from the offerings be used?

The net proceeds may be used for general corporate purposes, reducing indebtedness, and potential future acquisitions.

What services will Atrium Research provide to Organto?

Atrium Research will provide paid equity research and investor relations services for an initial 12-month period.